Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 1536-1541, March 15, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rao, V. V.
Right arrow Articles by Piwnica-Worms, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rao, V. V.
Right arrow Articles by Piwnica-Worms, D.

MDR1 Gene-specific Monoclonal Antibody C494 Cross-Reacts with Pyruvate Carboxylase1

Vailabhaneni V. Rao, Douglas C. Anthony and David Piwnica-Worms2,3

Laboratory of Molecular Radiopharmacology, Department of Radiology [V. V. R., D. P-W.], and Department of Pathology [D. C. A.], Harvard Medical School, Brigham and Women's Hospital and Children's Hospital, Boston, Massachusetts 02115

Overexpression of P-glycoprotein, the plasma membrane protein product of the MDR1 gene, is a major determinant in the development of resistance to a large number of cancer chemotherapeutic agents. A battery of antibodies, including the MDR1 gene-specific monoclonal antibody (mAb) C494, is used to evaluate human tissues in clinical multidrug resistance surveillance and modulation trials. In rat liver fractions, we report that mAb C494 strongly cross-reacted with a nonmembranous Mr ~130,000 protein, comigrating with core-glycosylated human MDR1 on 7% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. By immunoblotting and microsequence analysis, this protein was identified as pyruvate carboxylase (PC), an abundant mitochondrial enzyme. A search of the National Center for Biotechnology Information data base, using the epitope-specific sequence of mAb C494, revealed that PC (mouse) contains four of the five most reactive amino acids (TLEG), located near the COOH-terminal end of PC at positions 1167–1170. mAb C494 specifically reacted with PC purified from bovine liver; immunoreactivity was completely abolished by preincubating mAb C494 in the presence of excess synthetic C494 epitope-specific peptide. Furthermore, in cryosections of human skeletal muscle, a tissue known not to express P-glycoprotein, peptide-displaceable immunohistochemical staining with mAb C494 showed a distinct mitochondrial pattern specific to type 1 fibers. Variable immunostaining results were obtained with formaldehyde-fixed, paraffinembedded muscle and isolated liver mitochondrial preparations. In summary, mAb C494 cross-reacted strongly with rat, bovine, and human PC. Caution is warranted in interpretation of immunoblots and immunohistochemical sections with this putative MDR1 gene-specific mAb.

1 This work was supported in part by a grant from the Milton Fund, Harvard Medical School, and by NIH Grant CA 09536.

2 To whom requests for reprints should be addressed, at Department of Radiology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115.

3 D. P-W. is an Established Investigator of the American Heart Association.

Received 7/20/93. Accepted 1/17/94.




This article has been cited by other articles:


Home page
BrainHome page
S. M. Sisodiya, W.-R. Lin, B. N. Harding, M. V. Squier, and M. Thom
Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy
Brain, January 1, 2002; 125(1): 22 - 31.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. S. Wunder, S. B. Bull, V. Aneliunas, P. D. Lee, A. M. Davis, C. P. Beauchamp, E. U. Conrad, R. J. Grimer, J. H. Healey, M. J. Rock, et al.
MDR1 Gene Expression and Outcome in Osteosarcoma: A Prospective, Multicenter Study
J. Clin. Oncol., July 14, 2000; 18(14): 2685 - 2694.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.